Vascular endothelial growth factor and neovascularization in astrocytic tumors

Pathology International

Volumn 48, Issue 2, 1998, Pages 109-114

  Takekawa, Yoshinori ^a   Sawada, Tatsuo ^b  

^a NIHON UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Astrocytic tumor; Immunohistochemistry; Neovascularization; p53 protein; Vascular endothelial growth factor

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0031970274     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03879.x     Document Type: Article

References (22)

1. Brem S, Cotran RS, Folkan J. Tumor angiogenesis: A quantitative method for histologic grading. J. Natl Cancer Inst. 1972; 48: 347-356.
2. Zama A, Tamura M, Inoue HK. Three-dimensional observations on microvascular growth in rat glioma using a vascular casting method. J. Cancer Res. Clin. Oncol. 1991; 117: 396-402.
3. Ohtani H. Glomeruloid structure as vascular reaction in human gastrointestinal carcinoma. Jpn. J. Cancer Res. 1992; 83: 1334-1340.
4. Kleihues P, Burger PC, Scheithauer BW. Histologic Typing of Tumors of the Central Nervous System. World Health Organization, 1993.
5. Nomura M, Yamagishi T, Harada S et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 1995; 270: 28 316-28 324.
6. Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 protentiates protein kinase induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969.
7. Plate KH, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its congnate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 1993; 53: 5822-5827.
8. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, regulatory mechanisms. Int. J. Cancer 1994; 59: 520-529.
9. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093.
10. Louis D. The p53 gene and protein in human brain tumors. J. Neuropathol. Exp. Neurol. 1994; 53: 11-21.
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutation in the p53 suppresser gene: Clues to cancer etiology and the molecular pathogenesis. Cancer Res. 1994; 54: 4855-4878.
12. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: A simple and reproducible method. Cancer 1988; 62: 2152-2165.
13. Gerdes J, Schwab U, Lemke H, Stain H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13-20.
14. Shinoda J, Hirayama H, Araki Y, Andho T, Sakai N, Yamada H. Morphological change of basement membrane associated with endothelial proliferation in astrocytic tumors: An immunohistochemical study of laminin. No To Shinkei 1989; 41: 263-271 (in Japanese with English abstract).
15. Takano S, Yoshii Y, Kondo S et al. Concentration of vascular endothelial growth factor in serum and tumor tissue of brain tumor patients. Cancer Res. 1996; 56: 2185-2190.
16. Lehnert M. Multidrug resistance in human cancer. J. Neurooncol. 1994; 22: 239-243.
17. Leenstra S, Troost D, Das PK, Claessen N, Becker AE, Bosch DA. Endothelial cell marker PAL-E reactivity in brain tumor, developing brain and brain disease. Cancer 1993; 72: 3061-3067.
18. Kono S, Rao JS, Bruner JM, Sawaya R. Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumor. J. Neuropathol. Exp. Neurol. 1994; 53: 256-262.
19. Finlay CA, Hinds PW, Tan TH, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell Biol. 1988; 7: 847-853.
20. Danks RA, Chopra G, Gonzales MF, Orian JM, Kaya AH. Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. Neurosurgery 1995; 37: 246-254.
21. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotny PJ, Jenkins RB. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationship and prognostic value. J. Neurosurg. 1997; 86: 121-130.
22. Manz R, Otte J, Thews G, Vaupel P. Relationship between size and oxygenation status of malignant tumors. Adv. Exp. Med. Biol. 1983; 159: 391-398.